Cargando…

Managing drug-induced QT prolongation in clinical practice

Many drug therapies are associated with prolongation of the QT interval. This may increase the risk of Torsades de Pointes (TdP), a potentially life-threatening cardiac arrhythmia. As the QT interval varies with a change in heart rate, various formulae can adjust for this, producing a ‘corrected QT’...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khatib, Rani, Sabir, Fatima R N, Omari, Caroline, Pepper, Chris, Tayebjee, Muzahir Hassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237186/ https://www.ncbi.nlm.nih.gov/pubmed/33122341 http://dx.doi.org/10.1136/postgradmedj-2020-138661

Ejemplares similares

Cardiac monitoring in memory clinics: national survey of UK practice
por: Crowther, George, et al.
Publicado: (2023)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

The predictive ability of the QT response in supine-standing test for drug induced QT prolongation
por: Hochstadt, A, et al.
Publicado: (2023)

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Multiple drugs: QT prolongation: case report
Publicado: (2022)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

QT Prolongation in Cancer Patients
por: Kim, Peter, et al.
Publicado: (2021)

Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
por: Choi, Young, et al.
Publicado: (2018)

Managing hypertension during the COVID-19 pandemic
por: Nadar, Sunil K., et al.
Publicado: (2020)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

QT Prolongation: Psychotropic medication versus illicit drugs
por: Florian, A., et al.
Publicado: (2022)

Reverse RAMP (REVRAMP) pacing: A novel anti tachycardia pacing technique
por: Tayebjee, Muzahir Hassan, et al.
Publicado: (2021)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

How to Diagnose and Manage QT Prolongation in Cancer Patients
por: Kim, Peter Y., et al.
Publicado: (2021)

Identifying potential drugs that induce QT prolongation using electronic medical records
por: Liu, Mei, et al.
Publicado: (2010)

Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose
por: Soroosh, Davood, et al.
Publicado: (2019)

Drug-induced QT prolongation in COVID-19 pneumonia: influence on in-hospital survival
por: García-Rodríguez, Daniel, et al.
Publicado: (2021)

Antipsychotic Medication and QT Prolongation
por: Chohan, Paramdip Singh, et al.
Publicado: (2015)

British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication
por: Lambiase, Pier D, et al.
Publicado: (2019)

The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation
por: Wiśniowska, Barbara, et al.
Publicado: (2016)

Drug-Induced QT Prolongation as a Result of an Escitalopram Overdose in a Patient with Previously Undiagnosed Congenital Long QT Syndrome
por: Singh, Paul, et al.
Publicado: (2014)

SARS-COV-2 VACCINE INDUCED MYOCARDITIS WITH SEVERE QT PROLONGATION
por: Martinez, Jake Cordell, et al.
Publicado: (2022)

Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
por: Choi, Byung Jin, et al.
Publicado: (2021)

HCQ induced QT prolongation- Primum non nocere
por: Mahendran, A.J., et al.
Publicado: (2020)

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
por: Rowe, Elizabeth J., et al.
Publicado: (2022)

“Takotsubo cardiomyopathy presenting with QT prolongation: an atypical presentation.”
por: Ali, Zain, et al.
Publicado: (2019)

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
por: Porta‐Sánchez, Andreu, et al.
Publicado: (2017)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

QT Prolongation due to Graves' Disease
por: Kulairi, Zain, et al.
Publicado: (2017)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Trousseau’s sign and QT prolongation in hypocalcaemia
por: Schnur, Jack, et al.
Publicado: (2021)

Drug interactions with QT-prolonging antibiotics: an epidemiological study in community pharmacies
por: Vandael, Eline, et al.
Publicado: (2015)

Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19
por: Schiavone, Marco, et al.
Publicado: (2022)

Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation
por: Zhang, Juan, et al.
Publicado: (2021)

Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis
por: Simon, Steven T, et al.
Publicado: (2022)

QT Prolongation-induced Seizures Masquerading as Depression with Mixed Features
por: Capilla Crespillo, A., et al.
Publicado: (2022)

Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Bonny, Aimé, et al.
Publicado: (2020)

Coronary Guidewires in Temporary Cardiac Pacing and Assessment of Myocardial Viability: Current Perspectives and Future Directions
por: Javid, Rabeia, et al.
Publicado: (2023)

Unraveling Structural Alerts in Marketed Drugs for Improving Adverse Outcome Pathway Framework of Drug-Induced QT Prolongation
por: Long, Wulin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_54tvlalgd1dhtkj6eqka68doso